Value proposition

Biotechnological platforms for early detection of airborne viruses | Support us on Ulule 🚀

We are a dedicated team of biotechnology and software engineers committed to addressing the global challenge of frequent respiratory disease outbreaks.

The main problem we address is the delay in the diagnosis of respiratory diseases, which generally occurs after the onset of symptoms.

🤯 In France alone, respiratory virus infections accounted for 40% of sick leaves in 2023, resulting in 150 000 hospitalisations and a staggering €2.2 billion loss in salaries for companies.

Our mission is to empower healthcare professionals and vulnerable populations with easy-to-use devices to monitor respiratory viruses in the air.

Our innovative technology offer a cost-effective, real-time alternative to the existing bulky and expensive analytical platforms that often require qualified personnel to interpret results.

A spin-off from SupBiotech Engineering School, in 2024 VAir has earned recognition as:

🏅One of the top-20 most promising entrepreneurial projects launched by students and alumni of the Paris-Saclay cluster

🏅Finalist (top-5) of the Prize 'Entreprendre pour demain', organised by Foundation Sopra Steria-Institut de France

🏅Finalist (top-8) of the Serge Weinberg Trophies, awarded by Foundation S (Sanofi), Future4Care, and 21st (CentraleSupélec)

Our Ulule campaign is live! Support our impactful project with as little as a price of your ☕️

➡️ https://ulule.com/vair